Eli Lilly and Company (LLY)
NYSE
Closed
Aug 21, 2026
Day's Range
1,230.0052 wk Range
694.23Overview - LLY - Eli Lilly and Company
Key Statistics
Valuation
Enterprise Value
1.16T
P/E (Trailing)
‪42.19‬
P/E (Forward)
‪26.57‬
PEG Ratio
‪1.60‬
Price / Sales (TTM)
‪14.05‬
Price / Book
‪33.03‬
EV / EBITDA
‪27.93‬
Profitability
Gross Margin
‪85.77%‬
Profit Margin
‪33.52%‬
Operating Margin
‪54.22%‬
Return on Assets
‪20.35%‬
Return on Equity
‪102.28%‬
Ownership
Shares Outstanding
891.50M
Float
888.95M
Short % of Shares Outstanding
‪1.01%‬
Held by Insiders
‪0.15%‬
Held by Institutions
‪85.41%‬
Price stats
Beta
‪0.50‬
50-Day Avg
‪1,179.58‬
200-Day Avg
‪1,052.98‬
Dividends
Payout Ratio
‪21.69%‬
Frequency
Quarterly
Analyst Consensus
29 analysts
Average price target
‪$ 1,310.90‬Shariah Compliance
Report Date: Feb 19, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - LLY - Eli Lilly and Company
Peers - LLY - Eli Lilly and Company
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on NYSE.
- LLYNYSEEli Lilly and Company1.11TMarket Cap+44.61%52-week change42.21P/E (Trailing)‪33.52%‬Profit Margin
- JNJNYSEJohnson & Johnson651.25BMarket Cap+33.98%52-week change31.50P/E (Trailing)‪21.48%‬Profit Margin
- ABBVNYSEAbbVie Inc.468.21BMarket Cap+21.67%52-week change75.06P/E (Trailing)‪9.80%‬Profit Margin
- MRKNYSEMerck & Co., Inc.376.36BMarket Cap+44.08%52-week change122.04P/E (Trailing)‪4.76%‬Profit Margin
- NVSNYSENovartis AG Sponsored ADR301.94BMarket Cap+21.29%52-week change24.00P/E (Trailing)‪22.50%‬Profit Margin
- SANNYSEBanco Santander S.A. Sponsored ADR212.65BMarket Cap+34.20%52-week change14.27P/E (Trailing)‪33.46%‬Profit Margin
- NVONYSENovo Nordisk A/S206.68BMarket Cap-20.54%52-week change11.59P/E (Trailing)‪35.34%‬Profit Margin
Profile Summary - LLY - Eli Lilly and Company
About
Eli Lilly and Company is a leading pharmaceutical company engaged in the discovery, development, manufacture, and sale of human pharmaceutical products. It focuses on innovative medicines addressing critical health needs in areas such as diabetes, oncology, immunology, neuroscience, obesity, cardiovascular diseases,…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
